NPPA notified regarding the fixation of the retail price of Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg + Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100 mg + Metformin Hydrochloride IP 500 mg

Jun 22, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on June 21, 2024, notified regarding the fixation of the retail price of Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg + Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100 mg + Metformin Hydrochloride IP 500 mg.

The following has been stated namely: -

• It has fixed the rate at Rs. 10.27/- for the Composition of Each film-coated tablet containing: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg + Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100 mg + Metformin Hydrochloride IP 500 mg.

[Notification no. - 19(3736)/2023/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT